Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Shares Issued (2016 - 2024)

Guided Therapeutics' Shares Issued history spans 13 years, with the latest figure at $535000.0 for Q4 2024.

  • For Q4 2024, Shares Issued changed N/A year-over-year to $535000.0; the TTM value through Dec 2024 reached $835000.0, changed N/A, while the annual FY2024 figure was $835000.0, N/A changed from the prior year.
  • Shares Issued for Q4 2024 was $535000.0 at Guided Therapeutics, up from $300000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $1.8 million in Q2 2021 and bottomed at -$1.8 million in Q3 2021.
  • The 5-year median for Shares Issued is $162500.0 (2022), against an average of $185583.3.
  • The largest annual shift saw Shares Issued soared 6920.0% in 2021 before it crashed 92.59% in 2022.
  • A 5-year view of Shares Issued shows it stood at -$128000.0 in 2020, then tumbled by 1271.09% to -$1.8 million in 2021, then surged by 151.11% to $897000.0 in 2022, then plummeted by 121.74% to -$195000.0 in 2023, then soared by 374.36% to $535000.0 in 2024.
  • Per Business Quant, the three most recent readings for GTHP's Shares Issued are $535000.0 (Q4 2024), $300000.0 (Q3 2024), and -$195000.0 (Q3 2023).